Even though we found that the SUMO pathway regulates PVR but not Nectin2 expression, it is likely that the up-regulation of PVR expression is sufficient to affect MM susceptibility to NK cell-mediated lysis. The gene discussed is NECTIN2; the disease is Miyoshi myopathy.